Tom Spurling serves as the Managing Director of Nova Eye Medical Limited, where he leverages his extensive expertise in the medical technology sector to drive growth and innovation. With a strong focus on expanding the company’s footprint in the US market, Tom has successfully led...
Tom Spurling serves as the Managing Director of Nova Eye Medical Limited, where he leverages his extensive expertise in the medical technology sector to drive growth and innovation. With a strong focus on expanding the company’s footprint in the US market, Tom has successfully led strategic initiatives that enhance the reach of Nova Eye's proprietary ophthalmic treatment technologies. Under his leadership, the company has gained recognition for its iTrack™ minimally invasive glaucoma surgery (MIGS) device, which has become a preferred choice among eye surgeons in over 100 countries.
Tom's role encompasses a diverse range of responsibilities, including overseeing product development, refining marketing strategies, and managing complex negotiations with stakeholders. His deep understanding of the medical devices landscape allows him to navigate the intricacies of acquisitions and equity capital markets, both in Australia and the USA. This expertise is crucial as Nova Eye Medical continues to innovate and expand its portfolio of electro-optical systems, ensuring that they meet the evolving needs of healthcare professionals and patients alike.
In addition to his operational acumen, Tom is adept at change management, guiding his team through the challenges of a rapidly evolving industry. His strategic planning skills are instrumental in aligning the company’s objectives with market demands, ultimately driving sustainable growth. With a commitment to excellence and a passion for improving patient outcomes, Tom Spurling is not only a leader at Nova Eye Medical but also a pivotal figure in the advancement of ophthalmic technologies worldwide.
